Delayed neurological deterioration after subarachnoid haemorrhage

Nature Reviews Neurology

Volumn 10, Issue 1, 2014, Pages 44-58

  Macdonald, R Loch ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLAZOSENTAN; COMPACTIN; DANTROLENE; DIHYDROPYRIDINE; ERYTHROPOIETIN; FASUDIL; HEMOGLOBIN; MAGNESIUM; NICARDIPINE; NIMODIPINE; SIMVASTATIN; SODIUM NITRITE; VASODILATOR AGENT; VERAPAMIL;

ANEURYSM RUPTURE; BLOOD BRAIN BARRIER; BLOOD VESSEL CLIP; BRAIN ANGIOGRAPHY; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; COMPLEMENT ACTIVATION; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DELIVERY SYSTEM; DRUG TARGETING; ELECTROCORTICOGRAPHY; ENCEPHALITIS; GENETIC ASSOCIATION; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; HYPOTENSION; INTRACRANIAL PRESSURE; LUNG DISEASE; MENTAL DETERIORATION; MICROTHROMBUS; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OXYGEN THERAPY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW; SUBARACHNOID HEMORRHAGE; THROMBOCYTE AGGREGATION; VASODILATATION;

BRAIN INJURIES; DISEASE PROGRESSION; ENCEPHALITIS; HUMANS; MODELS, NEUROLOGICAL; NEUROIMAGING; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84891827270     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2013.246     Document Type: Review

References (155)

1. Feigin, V. L., Lawes, C. M., Bennett, D. A., Barker-Collo, S. L. & Parag, V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol. 8, 355-369 (2009
2. Lovelock, C. E., Rinkel, G. J. & Rothwell, P. M. Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology 74, 1494-1501 (2010
3. Taylor, T. N. et al. Lifetime cost of stroke in the United States. Stroke 27, 1459-1466 (1996
4. Al-Khindi, T., Macdonald, R. L. & Schweizer, T. A. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 41, e519-e536 (2010
5. Pickard, J. D. et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298, 636-642 (1989
6. Molyneux, A. et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: A randomised trial. Lancet 360, 1267-1274 (2002
7. Etminan, N., Vergouwen, M. D., Ilodigwe, D. & Macdonald, R. L. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. J. Cereb. Blood Flow Metab. 31, 1443-1451 (2011
8. Hinson, H. E. & Sheth, K. N. Manifestations of the hyperadrenergic state after acute brain injury. Curr. Opin. Crit. Care 18, 139-145 (2012
9. Tam, A. K. et al. Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: Exploratory analysis of CONSCIOUS 1 database. Neurocrit. Care 13, 182-189 (2010
10. Gao, C. et al. Relationship between sympathetic nervous activity and inflammatory response after subarachnoid hemorrhage in a perforating canine model. Auton. Neurosci. 147, 70-74 (2009
11. Rosengart, A. J., Schultheiss, K. E., Tolentino, J. & Macdonald, R. L. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 38, 2315-2321 (2007
12. Starke, R. M. & Connolly, E. S. Jr. Rebleeding after aneurysmal subarachnoid hemorrhage. Neurocrit. Care 15, 241-246 (2011
13. Lo, B. W., Macdonald, R. L., Baker, A. & Levine, M. A. Clinical outcome prediction in aneurysmal subarachnoid hemorrhage using bayesian neural networks with fuzzy logic inferences. Comput. Math. Methods Med. 2013, 904860 (2013
14. Sehba, F. A., Hou, J., Pluta, R. M. & Zhang, J. H. The importance of early brain injury after subarachnoid hemorrhage. Prog. Neurobiol. 97, 14-37 (2012
15. Mahaney, K. B., Todd, M. M., Bayman, E. O. & Torner, J. C. Acute postoperative neurological deterioration associated with surgery for ruptured intracranial aneurysm: Incidence, predictors, and outcomes. J. Neurosurg. 116, 1267-1278 (2012
16. Broderick, J. P., Brott, T. G., Duldner, J. E., Tomsick, T. & Leach, A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25, 1342-1347 (1994
17. Macdonald, R. L., Rosengart, A., Huo, D. & Karrison, T. Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J. Neurosurg. 99, 644-652 (2003
18. Dorhout Mees, S. M., Kerr, R. S., Rinkel, G. J., Algra, A. & Molyneux, A. J. Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the International Subarachnoid Aneurysm Trial (ISAT). J. Neurol. 259, 679-683 (2012
19. Chou, C. H. et al. Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 67, 345-352 (2010
20. Dorsch, N. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. Acta Neurochir. Suppl. 110, 5-6 (2011
21. Rosengart, A. J. et al. Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J. Neurosurg. 107, 253-260 (2007
22. Ducruet, A. F. et al. Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 30, 676-688 (2010
23. Khurana, V. G. et al. Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. J. Cereb. Blood Flow Metab. 24, 291-297 (2004
24. Vergouwen, M. D. et al. Plasminogen activator inhibitor 1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 35, 1280-1283 (2004
25. Fisher, C. M., Kistler, J. P. & Davis, J. M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6, 1-9 (1980
26. Reilly, C., Amidei, C., Tolentino, J., Jahromi, B. S. & Macdonald, R. L. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J. Neurosurg. 101, 255-261 (2004
27. Kramer, A. H. & Fletcher, J. J. Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. Neurocrit. Care 14, 489-499 (2011
28. Pluta, R. M. et al. Cerebral vasospasm following subarachnoid hemorrhage: Time for a new world of thought. Neurol. Res. 31, 151-158 (2009
29. Haley, E. C. Jr, Kassell, N. F. & Torner, J. C. A randomized trial of nicardipine in subarachnoid hemorrhage: Angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J. Neurosurg. 78, 548-553 (1993
30. Macdonald, R. L. et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS 1): Randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39, 3015-3021 (2008
31. Vorkapic, P., Bevan, J. A. & Bevan, R. D. Longitudinal in vivo and in vitro time-course study of chronic cerebrovasospasm in the rabbit basilar artery. Neurosurg. Rev. 14, 215-219 (1991
32. Crowley, R. W. et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 42, 919-923 (2011
33. Dorhout Mees, S. M. et al. Calcium antagonists for aneurysmal subarachnoid hemorrhage. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD000277. http://dx.doi.org/10.1002/14651858.CD000277.pub3
34. Vergouwen, M. D., Vermeulen, M., Coert, B. A., Stroes, E. S. & Roos, Y. B. Microthrombosis after aneurysmal subarachnoid hemorrhage: An additional explanation for delayed cerebral ischemia. J. Cereb. Blood Flow Metab. 28, 1761-1770 (2008
35. Dreier, J. P. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat. Med. 17, 439-447 (2011
36. Stein, S. C., Browne, K. D., Chen, X. H., Smith, D. H. & Graham, D. I. Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: An autopsy study. 59, 781-787 (2006
37. Schubert, G. A., Seiz, M., Hegewald, A. A., Manville, J. & Thome, C. Acute hypoperfusion immediately after subarachnoid hemorrhage: A xenon contrast-enhanced CT study. J. Neurotrauma 26, 2225-2231 (2009
38. Sehba, F. A., Mostafa, G., Friedrich, V. Jr & Bederson, J. B. Acute microvascular platelet aggregation after subarachnoid hemorrhage. J. Neurosurg. 102, 1094-1100 (2005
39. Friedrich, V., Flores, R., Muller, A. & Sehba, F. A. Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage. Brain Res. 1354, 179-187 (2010
40. Sabri, M. et al. Mechanisms of microthrombi formation after experimental subarachnoid hemorrhage. Neuroscience 224, 26-37 (2012
41. Friedrich, V., Flores, R., Muller, A. & Sehba, F. A. Escape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhage. Neuroscience 165, 968-975 (2010
42. Hossmann, K. A. Reperfusion of the brain after global ischemia: Hemodynamic disturbances. Shock 8, 95-101 (1997
43. Stoltenburg-Didinger, G. & Schwarz, K. in Stroke and Microcirculation (eds Cervos-Navarro, J. & Ferszt, R.) 471-480 (Raven Press, 1987
44. Suzuki, S., Suzuki, M., Iwabuchi, T. & Kamata, Y. Role of multiple cerebral microthrombosis in symptomatic cerebral vasospasm: With a case report. Neurosurgery 13, 199-203 (1983
45. Romano, J. G. et al. Microemboli in aneurysmal subarachnoid hemorrhage. J. Neuroimaging 18, 396-401 (2008
46. Larsen, C. C., Hansen-Schwartz, J., Nielsen, J. D. & Astrup, J. Blood coagulation and fibrinolysis after experimental subarachnoid hemorrhage. Acta Neurochir. (Wien) 152, 1577-1581 (2010
47. Pisapia, J. M. et al. Microthrombosis after experimental subarachnoid hemorrhage: Time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan. Exp. Neurol. 233, 357-363 (2012
48. Doczi, T., Joo, F., Adam, G., Bozoky, B. & Szerdahelyi, P. Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model. Neurosurgery 18, 733-739 (1986
49. Germano, A., d'Avella, D., Imperatore, C., Caruso, G. & Tomasello, F. Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir. (Wien) 142, 575-580 (2000
50. Friedrich, B., Muller, F., Feiler, S., Scholler, K. & Plesnila, N. Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: An in-vivo microscopy study. J. Cereb. Blood Flow Metab. 32, 447-455 (2012
51. Britz, G. W. et al. Time-dependent alterations in functional and pharmacological arteriolar reactivity after subarachnoid hemorrhage. Stroke 38, 1329-1335 (2007
52. Park, K. W., Metais, C., Dai, H. B., Comunale, M. E. & Sellke, F. W. Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage. Anesth. Analg. 92, 990-996 (2001
53. Rothoerl, R. D. & Ringel, F. Molecular mechanisms of cerebral vasospasm following aneurysmal SAH. Neurol. Res. 29, 636-642 (2007
54. Pradilla, G., Chaichana, K. L., Hoang, S., Huang, J. & Tamargo, R. J. Inflammation and cerebral vasospasm after subarachnoid hemorrhage. Neurosurg. Clin. N. Am. 21, 365-379 (2010
55. Macdonald, R. L. & Weir, B. K. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22, 971-982 (1991
56. Chaichana, K. L., Levy, A. P., Miller-Lotan, R., Shakur, S. & Tamargo, R. J. Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage. Stroke 38, 3266-3271 (2007
57. Borsody, M., Burke, A., Coplin, W., Miller-Lotan, R. & Levy, A. Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage. Neurology 66, 634-640 (2006
58. Peterson, J. W., Candia, G., Spanos, A. J. & Zervas, N. T. The calmodulin antagonist trifluoperazine provides mild prophylactic protection against cerebral vasospasm after subarachnoid hemorrhage, but no therapeutic value. Neurosurgery 25, 917-922 (1989
59. German, J. W., Gross, C. E., Giclas, P., Watral, W. & Bednar, M. M. Systemic complement depletion inhibits experimental cerebral vasospasm. Neurosurgery 39, 141-145 (1996
60. Kaura, V. & Bonner, S. Subarachnoid haemorrhage: Early clinical indicators and biomarkers. Trends Anaesth. Crit. Care 2, 42-47 (2012
61. Lad, S. P., Hegen, H., Gupta, G., Deisenhammer, F. & Steinberg, G. K. Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. J. Stroke Cerebrovasc. Dis. 21, 30-41 (2012
62. Bavbek, M. et al. Monoclonal antibodies against ICAM 1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 29, 1930-1935 (1998
63. Thai, Q. A., Oshiro, E. M. & Tamargo, R. J. Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers. Stroke 30, 140-147 (1999
64. Tiebosch, I. A. et al. Effect of interferon-ß on neuroinflammation, brain injury and neurological outcome after experimental subarachnoid hemorrhage. Neurocrit. Care 18, 96-105 (2013
65. Feigin, V. et al. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD004583. http://dx.doi.org/10.1002/14651858.CD004583.pub2
66. Gomis, P. et al. Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. J. Neurosurg. 112, 681-688 (2010
67. Vergouwen, M. D., de Haan, R. J., Vermeulen, M. & Roos, Y. B. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis update. Stroke 41, e47-e52 (2010
68. Tseng, M. Y. Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage. Neurocrit. Care 15, 298-301 (2011
69. Lo, E. H., Dalkara, T. & Moskowitz, M. A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415 (2003
70. Iadecola, C. & Anrather, J. The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808 (2011
71. Park, S. et al. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 35, 2412-2417 (2004
72. Sasaki, T., Kassell, N. F., Yamashita, M., Fujiwara, S. & Zuccarello, M. Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J. Neurosurg. 63, 433-440 (1985
73. Yatsushige, H., Ostrowski, R. P., Tsubokawa, T., Colohan, A. & Zhang, J. H. Role of c Jun N terminal kinase in early brain injury after subarachnoid hemorrhage. J. Neurosci. Res. 85, 1436-1448 (2007
74. Yan, J. et al. Blood-brain barrier disruption following subarachnoid hemorrhage may be facilitated through PUMA induction of endothelial cell apoptosis from the endoplasmic reticulum. Exp. Neurol. 230, 240-247 (2011
75. Doczi, T. The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage. Clinical and experimental studies. Acta Neurochir. 77, 110-132 (1985
76. Yang, Y. & Rosenberg, G. A. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42, 3323-3328 (2011
77. Koide, M., Bonev, A. D., Nelson, M. T. & Wellman, G. C. Inversion of neurovascular coupling by subarachnoid blood depends on large-conductance Ca2+-activated K+ (BK) channels. Proc. Natl Acad. Sci. USA 109, E1387-E1395 (2012
78. Leao, A. A. Spreading depression of activity in the cerebral cortex. J. Neurophysiol. 7, 359-390 (1944
79. de Rooij, N. K., Rinkel, G. J., Dankbaar, J. W. & Frijns, C. J. Delayed cerebral ischemia after subarachnoid hemorrhage: A systematic review of clinical, laboratory, and radiological predictors. Stroke 44, 43-54 (2013
80. Petruk, K. C. et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J. Neurosurg. 68, 505-517 (1988
81. Vergouwen, M. D. et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: Proposal of a multidisciplinary research group. Stroke 41, 2391-2395 (2010
82. Diringer, M. N. et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: Recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit. Care 15, 211-240 (2011
83. Rabinstein, A. A., Weigand, S., Atkinson, J. L. & Wijdicks, E. F. Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 36, 992-997 (2005
84. Schmidt, J. M. et al. Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J. Neurosurg. 109, 1052-1059 (2008
85. Vergouwen, M. D., Ilodigwe, D. & Macdonald, R. L. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 42, 924-929 (2011
86. Crobeddu, E. et al. Predicting the lack of development of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 43, 697-701 (2012
87. Chaudhary, S. R. et al. Prospective evaluation of multidetector-row CT angiography for the diagnosis of vasospasm following subarachnoid hemorrhage: A comparison with digital subtraction angiography. Cerebrovasc. Dis. 25, 144-150 (2008
88. Wintermark, M. et al. Vasospasm after subarachnoid hemorrhage: Utility of perfusion CT and CT angiography on diagnosis and management. AJNR Am. J. Neuroradiol. 27, 26-34 (2006
89. Dankbaar, J. W. et al. Diagnosing delayed cerebral ischemia with different CT modalities in patients with subarachnoid hemorrhage with clinical deterioration. Stroke 40, 3493-3498 (2009
90. Fontanella, M. et al. Vasospasm after SAH due to aneurysm rupture of the anterior circle of Willis: Value of TCD monitoring. Neurol. Res. 30, 256-261 (2008
91. Budohoski, K. P. et al. Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective observational study. Stroke 43, 3230-3237 (2012
92. Kistka, H., Dewan, M. C. & Mocco, J. Evidence-based cerebral vasospasm surveillance. Neurol. Res. Int. 2013, 256713 (2013
93. Claassen, J., Mayer, S. A. & Hirsch, L. J. Continuous EEG monitoring in patients with subarachnoid hemorrhage. J. Clin. Neurophysiol. 22, 92-98 (2005
94. Vespa, P. M. et al. Early detection of vasospasm after acute subarachnoid hemorrhage using continuous EEG ICU monitoring. Electroencephalogr. Clin. Neurophysiol. 103, 607-615 (1997
95. Hanggi, D. Monitoring and detection of vasospasm II: EEG and invasive monitoring. Neurocrit. Care 15, 318-323 (2011
96. Unterberg, A. W., Sakowitz, O. W., Sarrafzadeh, A. S., Benndorf, G. & Lanksch, W. R. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J. Neurosurg. 94, 740-749 (2001
97. Vajkoczy, P., Horn, P., Thome, C., Munch, E. & Schmiedek, P. Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J. Neurosurg. 98, 1227-1234 (2003
98. Macdonald, R. L. et al. Subarachnoid Hemorrhage International Trialists data repository (SAHIT). World Neurosurg. 79, 418-422 (2013
99. Macdonald, R. L. et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: A randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS 2). Lancet Neurol. 10, 618-625 (2011
100. Macdonald, R. L. et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 43, 1463-1469 (2012
101. Vergouwen, M. D., Algra, A. & Rinkel, G. J. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis update. Stroke 43, 2671-2676 (2012
102. Yamaguchi, S. et al. Involvement of Rho-kinase in tumor necrosis factor a induced interleukin 6 release from C6 glioma cells. Neurochem. Int. 55, 438-445 (2009
103. Satoh, S. et al. Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage. Brain Res. Bull. 81, 191-195 (2010
104. Liu, G. J. et al. Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur. J. Clin. Pharmacol. 68, 131-139 (2011
105. Li, F. et al. The protective effect of dantrolene on ischemic neuronal cell death is associated with reduced expression of endoplasmic reticulum stress markers. Brain Res. 1048, 59-68 (2005
106. Muehlschlegel, S., Rordorf, G. & Sims, J. Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: A prospective pilot study. Stroke 42, 1301-1306 (2011
107. Pluta, R. M. New regulatory, signaling pathways, and sources of nitric oxide. Acta Neurochir. Suppl. 110, 7-12 (2011
108. Oldfield, E. H. et al. Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: A phase IIA study. J. Neurosurg. 119, 634-641 (2013
109. Omeis, I., Jayson, N. A., Murali, R. & Abrahams, J. M. Treatment of cerebral vasospasm with biocompatible controlled-release systems for intracranial drug delivery. Neurosurgery 63, 1011-1019 (2008
110. Barth, M. et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: A prospective, randomized, double-blind phase IIa study. Stroke 38, 330-336 (2007
111. Krischek, B., Kasuya, H., Onda, H. & Hori, T. Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: Effect and outcome in the first 100 patients. Neurol. Med. Chir. (Tokyo) 47, 389-394 (2007
112. Dorhout Mees, S. M., van den Bergh, W. M., Algra, A. & Rinkel, G. J. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD006184. http://dx.doi.org/10.1002/ 14651858.CD006184.pub2
113. Cronqvist, M. et al. Diffusion and perfusion MRI in patients with ruptured and unruptured intracranial aneurysms treated by endovascular coiling: Complications, procedural results, MR findings and clinical outcome. Neuroradiology 47, 855-873 (2005
114. van den Bergh, W. M., Kerr, R. S., Algra, A., Rinkel, G. J. & Molyneux, A. J. Effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage. Stroke 40, 1969-1972 (2009
115. Suarez, J. I. et al. Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J. Neurosurg. 100, 585-590 (2004
116. Suarez, J. I. et al. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: Safety and neurologic outcomes. Stroke 43, 683-690 (2012
117. Springborg, J. B. et al. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br. J. Pharmacol. 135, 823-829 (2002
118. Grasso, G. et al. Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc. Natl Acad. Sci. USA 99, 5627-5631 (2002
119. Tsai, P. T. et al. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J. Neurosci. 26, 1269-1274 (2006
120. Tseng, M. Y. et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: A phase II randomized, double-blind, placebo-controlled trial. Clinical article. J. Neurosurg. 111, 171-180 (2009
121. Springborg, J. B. et al. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: A double blind randomised clinical trial. Acta Neurochir. (Wien) 149, 1089-1101 (2007
122. Liao, J. K. & Laufs, U. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45, 89-118 (2005
123. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/show/NCT00731627 (2011
124. Wong, G. K. et al. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: A multicenter, randomized, controlled, double-blind clinical trial protocol. Neurosurgery 72, 840-844 (2013
125. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/show/NCT01077206 (2013
126. Euser, A. G. & Cipolla, M. J. Magnesium sulfate for the treatment of eclampsia: A brief review. Stroke 40, 1169-1175 (2009
127. Mees, S. M. et al. Magnesium for aneurysmal subarachnoid haemorrhage (MASH 2): A randomised placebo-controlled trial. Lancet 380, 44-49 (2012
128. Muroi, C., Terzic, A., Fortunati, M., Yonekawa, Y. & Keller, E. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: A randomized, placebo-controlled, dose-adapted trial. Surg. Neurol. 69, 33-39 (2008
129. Wong, G. K. Magnesium for aneurysmal subarachnoid haemorrhage. Lancet 380, 1381 (2012
130. McKee, J. A. et al. Magnesium neuroprotection is limited in humans with acute brain injury. Neurocrit. Care 2, 342-351 (2005
131. Mori, K. et al. Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurol. Med. Chir. (Tokyo) 49, 139-144 (2009
132. Manno, E. M., Gress, D. R., Ogilvy, C. S., Stone, C. M. & Zervas, N. T. The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: A pilot study. Neurosurgery 40, 289-293 (1997
133. Yanamoto, H. et al. Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT 175, administered in the acute stage after subarachnoid hemorrhage. Neurosurgery 30, 358-363 (1992
134. Young, A. M., Karri, S. K. & Ogilvy, C. S. Non-steroidal anti-inflammatory drugs used as a treatment modality in subarachnoid hemorrhage. Curr. Drug Saf. 7, 197-201 (2012
135. Klimo, P. Jr, Kestle, J. R., Macdonald, J. D. & Schmidt, R. H. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J. Neurosurg. 100, 215-224 (2004
136. Al-Tamimi, Y. Z. et al. Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: A prospective, randomized, controlled trial (LUMAS). Stroke 43, 677-682 (2012
137. Senbokuya, N. et al. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: A multicenter prospective, randomized, open-label blinded end point trial. J. Neurosurg. 118, 121-130 (2013
138. Connolly, E. S. Jr et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 43, 1711-1737 (2012
139. Le Roux, P. D. Anemia and transfusion after subarachnoid hemorrhage. Neurocrit. Care 15, 342-353 (2011
140. Treggiari, M. M. Hemodynamic management of subarachnoid hemorrhage. Neurocrit. Care 15, 329-335 (2011
141. Dhar, R. et al. Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage. J. Neurosurg. 116, 648-656 (2012
142. Lennihan, L. et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: A randomized controlled trial. Stroke 31, 383-391 (2000
143. Dankbaar, J. W., Slooter, A. J., Rinkel, G. J. & van der Schaaf, I. C. Effect of different components of triple H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: A systematic review. Crit. Care 14, R23 (2010
144. Muench, E. et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit. Care Med. 35, 1844-1851 (2007
145. Raabe, A. et al. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J. Neurosurg. 103, 974-981 (2005
146. Hasan, D., Vermeulen, M., Wijdicks, E. F., Hijdra, A. & van Gijn, J. Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke 20, 1511-1515 (1989
147. Zubkov, Y. N., Nikiforov, B. M. & Shustin, V. A. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir. (Wien) 70, 65-79 (1984
148. Zwienenberg-Lee, M. et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: Results of a phase II multicenter, randomized, clinical trial. Stroke 39, 1759-1765 (2008
149. Kimball, M. M., Velat, G. J. & Hoh, B. L. Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit. Care 15, 336-341 (2011
150. DeWitt, C. R. & Waksman, J. C. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol. Rev. 23, 223-238 (2004
151. Albanese, E. et al. Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: Initial experience. J. Neurosurg. 113, 913-922 (2010
152. Volk, J. M., Culicchia, F. & Dawson, R. Use of intra-arterial infusion of calcium-channel blockers through an indwelling microcatheter: One institution's experience. Stroke 43, A47 (2012
153. Bulters, D. O. et al. A randomized controlled trial of prophylactic intra-aortic balloon counterpulsation in high-risk aneurysmal subarachnoid hemorrhage. Stroke 44, 224-226 (2013
154. Wong, G. K., Chan, M. T., Gin, T. & Poon, W. S. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: Current status. Acta Neurochir. Suppl. 110, 169-173 (2011
155. Ryba, M., Pastuszko, M., Iwanska, K., Bidzinski, J. & Dziewiecki, C. Cyclosporine A prevents neurological deterioration of patients with SAH- A preliminary report. Acta Neurochir. 112, 25-27 (1991